z-logo
open-access-imgOpen Access
Nasal Apocrine Hydrocistoma
Author(s) -
Costa Viviane,
Viana Fernanda M. L.,
Barnewitz Joao P.,
Doria Thais,
Riberiro Thais K.,
Ribeiro Ulisses J.
Publication year - 2011
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599811415823a61
Subject(s) - medicine , nose , apocrine , differential diagnosis , physical examination , cyst , surgery , anatomy , pathology
Objective Describe a case report of an apocrine hydrocistoma of unusual presentation site (nasal) and a literature review. Its pathogeny seems to be a result of the sudoriferous conduct obstruction just above the glandular wound, due to trauma or an inflammatory process. Method Female, 43 years‐old, complaining of a swelling over the right side of the nose, associated to pain and nasal obstruction over 1 year. The examination showed facial asymmetry with an elevated right nasal wing and bulging of nasal floor. We performed cyst resection. Results This case shows a nasal apocrine hydrocistoma that differs from its usual eyelid location. The patient’s clinical and physical history, as well CT scan images, guided us to cyst resection with an intraoral access. The anatomopathology study proved to be an apocrine hydrocistoma. The literature review points this case report as a differential diagnosis for diseases in this area, such as inflammatory periapical lesions, nasal boils, nasopalatine duct cysts, dermoid cysts, and nasolabial cysts. Conclusion Apocrine hydrocistomas are sudoriferous gland benign tumors in the face. Most people present themselves with a well‐delimitated swelling, local pain, and partial or complete nasal obstruction. CT is the ideal examination for its evaluation, with anatomopathology to confirm the diagnosis. Cyst resection is a choice treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here